alpha-Mannosidosis: Clinical Trials

6 trials for alpha-Mannosidosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated, 1 withdrawn. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Terminated 1, Withdrawn 1

Follow alpha-Mannosidosis: new trials by email Literature Review of alpha-Mannosidosis trials Research Report on alpha-Mannosidosis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis
Velmanase Alfa, Placebo - Alpha-Mannosidosis
Phase 3WithdrawnChiesi Farmaceutici S.p.A.2021-01-112020-12-08
Evaluation of Long-term Efficacy of Treatment With Lamazym
Lamazym - Alpha-Mannosidosis
Phase 3CompletedZymenex A/S182015-02-012020-11-20
Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients
Lamazym - Alpha-Mannosidosis
Phase 3CompletedChiesi Farmaceutici S.p.A.132013-08-012023-07-28
Lamazym Aftercare Study
Lamazym - Alpha-Mannosidosis
Phase 3CompletedChiesi Farmaceutici S.p.A.82013-06-012023-07-28
A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis
Lamazym, Placebo - Alpha-Mannosidosis
Phase 3CompletedZymenex A/S252012-08-012020-08-03
ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases
ALD-101 - Inherited Metabolic Diseases, Lysosomal Storage Disorders
Phase 3TerminatedAldagen402008-03-012014-07-08

Narrower conditions

Adrenoleukodystrophy (1)  ·  Canavan Disease (1)  ·  Fucosidosis (1)  ·  Gangliosidosis, GM1 (1)  ·  Leukodystrophy, Globoid Cell (1)  ·  Leukodystrophy, Metachromatic (1)  ·  Lysosomal Storage Diseases (1)  ·  Mannosidase Deficiency Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucolipidoses (1)  ·  Mucopolysaccharidoses (1)  ·  Mucopolysaccharidosis I (1)  ·  Mucopolysaccharidosis II (1)  ·  Mucopolysaccharidosis III (1)

Broader conditions

Carbohydrate Metabolism, Inborn Errors (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Genetic Diseases, Inborn (6)  ·  Metabolic Diseases (6)  ·  Nutritional and Metabolic Diseases (6)  ·  Lysosomal Storage Diseases (5)  ·  Mannosidase Deficiency Diseases (5)  ·  Metabolism, Inborn Errors (5)  ·  Adrenal Gland Diseases (1)  ·  Adrenal Insufficiency (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)

Sponsors

Chiesi Farmaceutici S.p.A. (3)  ·  Zymenex A/S (2)  ·  Aldagen (1)

Countries

Denmark (3)  ·  France (2)  ·  Germany (1)  ·  Poland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Allan M Lund, MD (2)  ·  James Hinson, MD (1)  ·  Jens Fogh (1)  ·  Jens M Fogh, DVM (1)  ·  Joanne Kurtzberg, MD (1)  ·  Paul Harmatz, MD (1)

Results publications

PMID 29716835, PMID 29725868, PMID 29846843